Publications by authors named "E M el-Omar"

Background/objectives: Growing evidence suggests that the gut-brain axis influences brain function, particularly the role of intestinal microbiota in modulating cognitive processes. Probiotics may alter brain function and behavior by modulating gut microbiota, with implications for neurodegenerative diseases like Alzheimer's disease (AD). The purpose of this review is to systematically review the current literature exploring the effects of probiotic supplementation on gut microbiota and cognitive function in AD and mild cognitive impairment (MCI).

View Article and Find Full Text PDF

Up to 50-70% of patients with liver cirrhosis develop hepatic encephalopathy (HE), which is closely related to gut microbiota dysbiosis, with an unclear mechanism. Here, by constructing gut-brain modules to assess bacterial neurotoxins from metagenomic datasets, we found that phenylalanine decarboxylase (PDC) genes, mainly from Ruminococcus gnavus, increased approximately tenfold in patients with cirrhosis and higher in patients with HE. Cirrhotic, not healthy, mice colonized with R.

View Article and Find Full Text PDF

There is growing interest in the potential exploitation of the gut microbiome as a diagnostic tool in medicine, but evidence supporting its clinical usefulness is scarce. An increasing number of commercial providers offer direct-to-consumer microbiome diagnostic tests without any consensus on their regulation or any proven value in clinical practice, which could result in considerable waste of individual and health-care resources and potential drawbacks in the clinical management of patients. We convened an international multidisciplinary expert panel to standardise best practices of microbiome testing for clinical implementation, including recommendations on general principles and minimum requirements for their provision, indications, pre-testing protocols, method of analyses, reporting of results, and potential clinical value.

View Article and Find Full Text PDF

Endometriosis is a chronic, inflammatory, oestrogen-dependent disorder that is defined by the presence of endometrium-like tissue in the extra-uterine environment. It is estimated to affect approximately 10% of women of reproductive age, and the cause is still largely unknown. The heterogenous nature and complex pathophysiology of the disease results in diagnostic and therapeutic challenges.

View Article and Find Full Text PDF
Article Synopsis
  • A pilot study aimed to identify a microbial signature for endometriosis as a non-invasive diagnostic tool was conducted in Australia, involving 64 participants divided into three groups: healthy controls, non-endometriosis patients, and those with confirmed endometriosis.
  • Self-collected samples from the oral cavity, stool, and vagina were analyzed using advanced sequencing techniques to uncover differences in microbial composition among the groups, with significant findings from both oral and stool microbiota.
  • Results revealed distinct microbiota profiles, particularly highlighting that Fusobacterium was more abundant in the oral samples of patients with moderate to severe endometriosis, suggesting the potential of using microbiome analysis for diagnosis and treatment strategies in endometriosis.
View Article and Find Full Text PDF